文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

左心室流出道梗阻:急诊临床医师叙述性综述

Left ventricular outflow tract obstruction: A narrative review for emergency clinicians.
PubMed 文献 · Am J Emerg Med · 2025-08-23
一句话结论对常规休克治疗(升压药、正性肌力药、利尿)反应恶化或加重的难治性休克患者,应考虑左心室流出道梗阻,超声是首选诊断方法,处理以增加左室容量和延长充盈时间为核心。

本文为面向急诊临床医师的叙述性综述,总结左心室流出道梗阻(LVOTO)的病理生理、表现、诊断与处理。LVOTO与解剖因素(左室流出道尺寸减小)和生理因素(外源性正性肌力药、高内源性交感张力、心动过速、前负荷或后负荷降低)相关。患者病情危重,查体可发现新出现收缩期杂音、心源性肺水肿和全身灌注不良,但诊断具有挑战性。超声是首选诊断方法,超声心动图显示左室流出道高流速、晚峰连续波多普勒呈典型匕首形,且左室流出道压力阶差≥30 mmHg。处理基于通过增加左室尺寸和延长充盈时间纠正流出道梗阻,包括治疗合并症(如脓毒症)、停用正性肌力药和利尿剂、容量复苏、使用去氧肾上腺素或血管加压素增加血管阻力、处理快速性心律失常,患者应收入重症监护病房。

要点

  • 对常规休克治疗(如低血压用升压药、心输出量差用正性肌力药、心源性肺水肿用利尿)反应恶化或加重的难治性休克患者,应考虑LVOTO。
  • 超声是LVOTO首选诊断方法:超声心动图显示左室流出道高流速、晚峰连续波多普勒呈典型匕首形,左室流出道压力阶差≥30 mmHg。
  • LVOTO处理核心是纠正流出道梗阻:增加左室尺寸和延长充盈时间,包括治疗合并症(如脓毒症)、停用正性肌力药和利尿剂、容量复苏。
  • 增加血管阻力可使用去氧肾上腺素或血管加压素,并需处理快速性心律失常。
  • LVOTO患者病情危重,应收入重症监护病房。

适用人群与场景

  • 急诊科就诊的左心室流出道梗阻患者。
  • 病情危重、存在难治性休克且对常规休克治疗(低血压用升压药、心输出量差用正性肌力药、心源性肺水肿用利尿)反应恶化或加重的患者。

诊断标准与关键阈值

  • 超声心动图显示左室流出道高流速、晚峰连续波多普勒呈典型匕首形,且左室流出道压力阶差≥30 mmHg。

处置流程与药物剂量

  • 治疗合并症(如脓毒症)。
  • 停用正性肌力药和利尿剂。
  • 容量复苏。
  • 使用去氧肾上腺素或血管加压素增加血管阻力。
  • 处理快速性心律失常。
  • 患者应收入重症监护病房。

红旗征与不能漏的情况

  • 新出现收缩期杂音。
  • 心源性肺水肿。
  • 全身灌注不良。
  • 难治性休克对常规休克治疗(低血压用升压药、心输出量差用正性肌力药、心源性肺水肿用利尿)反应恶化或加重。

研究设计与关键结果

  • 本文为叙述性综述,基于当前证据总结LVOTO的病理生理、表现、诊断和处理。
  • LVOTO与解剖因素(左室流出道尺寸减小)和生理因素(外源性正性肌力药、高内源性交感张力、心动过速、前负荷或后负荷降低)相关。
  • 超声是诊断首选方法,超声心动图显示左室流出道高流速、晚峰连续波多普勒呈典型匕首形,左室流出道压力阶差≥30 mmHg。
  • 管理基于通过增加左室尺寸和延长充盈时间纠正流出道梗阻,包括治疗合并症、停用正性肌力药和利尿剂、容量复苏、使用去氧肾上腺素或血管加压素增加血管阻力、处理快速性心律失常,患者应收入重症监护病房。

证据类型、等级与局限

  • 证据类型:叙述性综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对常规休克治疗反应恶化或加重的难治性休克患者,急诊临床医师应考虑LVOTO,并使用超声进行诊断。
  • 确诊LVOTO后,应停用正性肌力药和利尿剂、进行容量复苏、使用去氧肾上腺素或血管加压素增加血管阻力,并处理快速性心律失常。
  • LVOTO患者应收入重症监护病房。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Patients with left ventricular (LV) outflow tract obstruction (LVOTO) can experience significant morbidity and mortality, but this condition is frequently misdiagnosed and inappropriately managed.

OBJECTIVE: This review, based on current evidence, highlights the pearls and pitfalls of LVOTO, including pathophysiology, presentation, diagnosis, and management in the emergency department (ED).

DISCUSSION: LVOTO is associated with obstruction of forward blood flow from the LV. The condition is associated with anatomic and physiological factors. Anatomic factors include those associated with reduced LV outflow tract size, while physiologic factors include exogenous inotropes, high endogenous sympathetic tone, tachycardia, and reduced preload or afterload. Patients with LVOTO are critically ill. Examination may reveal a new systolic murmur, cardiogenic pulmonary edema, and poor systemic perfusion. However, LVOTO can be a challenging diagnosis. Clinicians should consider LVOTO in those with refractory shock that worsens with conventional shock treatments (e.g., vasopressors for hypotension, inotropes for poor cardiac output, and diuresis for cardiogenic pulmonary edema). Ultrasound is the diagnostic modality of choice, with echocardiogram demonstrating high-velocity, late-peaking continuous-wave Doppler through the LV with classic dagger shape and LVOT pressure gradient ≥30 mmHg. Management is based on correcting the outflow obstruction by increasing LV size and prolonging filling time. This includes treating concomitant illness (e.g., sepsis), stopping inotropes and diuretics, volume resuscitation, increasing vascular resistance with phenylephrine or vasopressin, and managing tachyarrhythmias. Patients should be admitted to a critical care setting.

CONCLUSIONS: LVOTO is a deadly condition, and a knowledge of this disease process can assist emergency clinicians.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Long B, Bridwell RE, Rapada R, et al. Left ventricular outflow tract obstruction: A narrative review for emergency clinicians. Am J Emerg Med. 2025. PMID: 40876217. doi:10.1016/j.ajem.2025.08.052

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。